Melatonin for the prevention and treatment of cancer

Abstract

// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Ya Li1, Sha Li2,*, Yue Zhou1, Xiao Meng1, Jiao-Jiao Zhang1, Dong-Ping Xu1 and Hua-Bin Li1,3,* 1 Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, China 2 School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China 3 South China Sea Bioresource Exploitation and Utilization Collaborative Innovation Center, Sun Yat-Sen University, Guangzhou, China Correspondence to: Hua-Bin Li, email: // <![CDATA[ mail("lihuabin","mail.sysu.edu",23,"") // ]]> Sha Li, email: // <![CDATA[ mail("u3003781","connect.hku",28,"") // ]]> Keywords: melatonin; anticancer; mechanisms of action; receptor; apoptosis Received: January 20, 2017 Accepted: March 09, 2017 Published: March 18, 2017